Baricitinib
Form: Tablet
Strength: 2 mg, 4 mg
Reference Brands: Olumiant®(EU & US- Emergency Use Authorization (EUA)
Category: Anti Covid Medicines
Baricitinib, marketed as Olumiant® by Eli Lilly, is a JAK inhibitor approved in the US and EU for rheumatoid arthritis and authorized for COVID-19 treatment in hospitalized adults. Available in 1 mg, 2 mg, and 4 mg oral tablets, it helps reduce inflammation and cytokine storms in severe COVID-19 cases. Through leading PharmaB2B platforms, global buyers can source Olumiant or Baricitinib generics from GMP-certified manufacturers in India, China, and Bangladesh. Ideal for hospital tenders and bulk procurement, Baricitinib is widely distributed with full regulatory support, competitive pricing, and fast international shipping.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Related Products
Nirmatrelvir + Ritonavir
Strength: Nirmatrelvir(150 mg) + Ritonavir(100 mg)
Form: Tablet
Reference Brands: Paxlovid®(US & EU- For Emergency Use Authorization)
View Details Get Enquiry
Tocilizumab
Strength: IV: 80 mg/4 mL, 200 mg/10 mL, 400 mg/20 mL; SQ: 162 mg/0.9 mL (pen or syringe)
Form: IV injection, SQ Injection
Reference Brands: Actemra®(US); RoActemra®(EU)
View Details Get Enquiry
Molnupiravir
Strength: 200 mg
Form: Oral capsule
Reference Brands: Lagevrio®(Us & EU)
View Details Get Enquiry
Favipiravir tablet
Strength: 200 mg, 400 mg, 600 mg
Form: Tablet
Reference Brands: Fabiflu, Favicovid, Covihalt, Avifavir, Avigan, Favira , Favilow(Globally, Not approved in USA & EU)
View Details Get Enquiry